# Short-term Effect of PCSK9 Inhibitor in Patients With Acute Ischemic Stroke

> **NCT06134635** · — · UNKNOWN · sponsor: **Xuanwu Hospital, Beijing** · enrollment: 80 (estimated)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** Statins
- **DRUG:** Evolocumab

## Key facts

- **NCT ID:** NCT06134635
- **Lead sponsor:** Xuanwu Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12-01
- **Primary completion:** 2024-11-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2023-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06134635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06134635, "Short-term Effect of PCSK9 Inhibitor in Patients With Acute Ischemic Stroke". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT06134635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*